Great find and well done everyone, this is gold. My confidence in Novartis confirming and GVHD getting up has increased immensely.
defintely holding now firm till april now, and this provides insurance for a bad CLBP read out. That is not really Novartis's concern, more of bonus score. How can they say no to a share in GVHD, CHF future products and ARDS with a side dressing of CLBP if it's tasty!
MSB to dispute FDA finding in Type A meeting, page-790
-
- There are more pages in this discussion • 228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |